4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-06-000026
Sr. VP Research & Development acquired 2,201 shares (code I)
From the SEC's structured data for this filing
Trades in this filing
LEVY MICHAEL D · Sr. VP Research & Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2005-08-31 | Other acquisition : show line 1 in the form | +1,500 | $6.33 | $9,495 | 2,986 | D |
| 2006-05-31 | Other acquisition : show line 2 in the form | +701 | $13.90 | $9,744 | 3,687 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2006-08-01 | Grant or award : show line 3 in the form Non Qualified Stock Option (right to buy) | +74,025 | $16.74 | 2016-08-01 | 74,025 | 74,025 | D |
| 2006-08-01 | Grant or award : show line 4 in the form Incentive Stock Option (right to buy) | +5,975 | $16.74 | 2016-08-01 | 5,975 | 5,975 | D |
Loading xslF345X02/edgar.xml…